Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 1.35% Nasdaq Down 1.12%
Streaming
Ticker Tape: On

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS

30.25 Up 0.26(0.87%) 3:59PM EDT|After Hours : 30.25 0.00 (0.00%) 4:07PM EDT

Add to Portfolio
Prev Close:29.99
Open:30.04
Bid:29.70 x 300
Ask:33.00 x 200
1y Target Est:32.17
Beta:1.94
Next Earnings Date: 5-Aug-13ALNY Earnings announcement
Day's Range:29.70 - 30.84
52wk Range:11.26 - 31.79
Volume:659,074
Avg Vol (3m):399,456
Market Cap:1.88B
P/E (ttm):N/A
EPS (ttm):-1.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALNYUp 0.87%1.88B
RHHBYN.MXUp 1.05%2.77T
SHP.LDown 0.05%11.50B
SUNPHARMA.NSDown 1.10%992.21B
GILD.MX 0.00%1.02T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-1.28
Quarterly EPS Est (Jun-13) :-0.34
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):3.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback